Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 8/20 | 0.72 |
| ▸ | MMP2 | P08253 | 6/20 | 0.63 |
| ▸ | LEF1 | Q9UJU2 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17414823 | 0.89 | MMP13 (0.64) | MMP13MMP2LEF1KDM4EALDH1A1 | |
| SCHEMBL6617416 | 0.88 | LEF1 (0.74) | MMP13MMP2LEF1KDM4EALDH1A1 | |
| SCHEMBL7833243 | 0.86 | LEF1 (0.55) | MMP13MMP2LEF1KDM4EALDH1A1 | |
| SCHEMBL8204370 | 0.85 | MMP13 (0.83) | MMP13MMP2KDM4EALDH1A1HPGD | |
| SCHEMBL8209912 | 0.85 | MMP13 (0.83) | MMP13MMP2KDM4EALDH1A1HPGD | |
| SCHEMBL28291191 | 0.84 | MMP13 (0.58) | MMP13MMP2LEF1KDM4EALDH1A1 | |
| SCHEMBL28291196 | 0.84 | MMP13 (0.58) | MMP13MMP2LEF1KDM4EALDH1A1 | |
| SCHEMBL3030225 | 0.84 | LEF1 (0.60) | MMP13MMP2LEF1KDM4EALDH1A1 | |
| SCHEMBL6514040 | 0.84 | MMP13 (1.00) | MMP13MMP2KDM4EALDH1A1HPGD | |
| SCHEMBL8209921 | 0.84 | MMP13 (0.81) | MMP13MMP2KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9758480-B2 | 1-(cycloalkyl-carbonyl)proline derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| US-9758480-B2 | 1-(cycloalkyl-carbonyl)proline derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| US-9718840-B2 | Condensed 5-oxazolidinone derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-08-01 | — | — | US | disclosed |
| US-9718840-B2 | Condensed 5-oxazolidinone derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-08-01 | — | — | US | disclosed |
| US-20170022218-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-01-26 | — | — | US | disclosed |
| US-20170022218-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-01-26 | — | — | US | disclosed |
| EP-3095786-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2016-11-23 | — | — | EP | disclosed |
| EP-3095786-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2016-11-23 | — | — | EP | disclosed |
| CN-106103453-A | It is condensed 5 oxazolidinone derivatives | 大日本住友制药株式会社 | 2016-11-09 | — | — | CN | disclosed |
| EP-2121667-B1 | CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF | SQUIBB & SONS LLC (US) | 2016-06-08 | — | — | EP | disclosed |
| US-20100145036-A1 | CHEMICAL LINKERS AND CLEAVABLE SUBSTRATES AND CONJUGATES THEREOF | MEDAREX, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100145036-A1 | CHEMICAL LINKERS AND CLEAVABLE SUBSTRATES AND CONJUGATES THEREOF | MEDAREX, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100113476-A1 | CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF | E. R. SQUIBB & SONS, L.L.C. | 2010-05-06 | — | — | US | disclosed |
| US-20100113476-A1 | CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF | E. R. SQUIBB & SONS, L.L.C. | 2010-05-06 | — | — | US | disclosed |
| EP-2166856-A1 | CHEMICAL COMPOUNDS | GlaxoSmithKline LLC (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008154271-A1 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008103693-A2 | CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF | MEDAREX, INC. (US) | 2008-08-28 | — | — | WO | disclosed |
| WO-2008083312-A2 | CHEMICAL LINKERS AND CLEAVABLE SUBSTRATES AND CONJUGATES THEREOF | MEDAREX, INC. (US) | 2008-07-10 | — | — | WO | disclosed |
| WO-2007038658-A2 | ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | MEDAREX, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| US-5843937-A | DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents | PANORAMA RESEARCH, INC. (US) | 1998-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113476-A1 | CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF | DNPEP, ANTXR2, CLSPN | MMP13 3531/4885MMP2 2699/4885LEF1 4834/4885 |
| US-20170022218-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | F2, SERPINC1, F12 | MMP13 1174/4885MMP2 1456/4885LEF1 1502/4885 |
| US-20100145036-A1 | CHEMICAL LINKERS AND CLEAVABLE SUBSTRATES AND CONJUGATES THEREOF | XIAP, ADAM8, CLSPN | MMP13 610/4885MMP2 222/4885LEF1 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.